Development of a Non-Invasive Prediction Model for MASLD Using Routine Clinical and Biochemical Markers: A Retrospective Study

Purpose

Metabolic dysfunction-associated steatotic liver disease (MASLD), formerly known as non-alcoholic fatty liver disease, is a leading chronic liver condition associated with obesity and metabolic syndrome. Practical non-invasive models based on commonly available clinical and biochemical indicators may support risk stratification in health-check settings.